ADC Therapeutics

ADC Therapeutics

ADC Therapeutics is a leading, commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). Our goal is to transform the lives of those impacted by cancer. We are focused on unlocking the potential value of our robust ADC portfolio in hematology and solid tumors. We have end-to-end capabilities unique to ADCs including a validated technology platform, a growing next-generation research & development toolbox and a proven track record including an approved, marketed product.

Biotechnology, Pharmaceuticals, Clinical Research, Patient Education Materials